Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary V Relling

Showing results (1-10 of 295) with videos related to

Pageof 30
Sort By:
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|November 3, 2012
Pharmacogenomics of adverse effects of anti-leukemic agents in childrenMary V Relling
Lancet (London, England)|September 15, 2004
Can the genotoxicity of chemotherapy be predicted?Ching-Hon Pui, Mary V Relling
Nature|May 28, 2004
Moving towards individualized medicine with pharmacogenomicsWilliam E Evans, Mary V Relling
Nature|October 16, 2015
Pharmacogenomics in the clinicMary V Relling, William E Evans
Hematology. American Society of Hematology. Education Program|December 10, 2013
Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacyMary V Relling, Laura B Ramsey
Pediatric Blood & Cancer|November 23, 2017
How to solve the problem of hypersensitivity to asparaginase?Ching-Hon Pui, Yiwei Liu, Mary V Relling
Blood|May 23, 2015
Inherited genetic variation in childhood acute lymphoblastic leukemiaTakaya Moriyama, Mary V Relling, Jun J Yang
Clinical Pharmacology and Therapeutics|September 15, 2019
Preemptively Precise: Returning and Updating Pharmacogenetic Test Results to Realize the Benefits of Preemptive TestingCyrine E Haidar, Mary V Relling, James M Hoffman
Nature Clinical Practice. Oncology|December 13, 2007
Are children with lesser-risk B-lineage acute lymphoblastic leukemia curable with antimetabolite therapy?Ching-Hon Pui, William E Evans, Mary V Relling
Leukemia & Lymphoma|December 16, 2006
Is mega dose of methotrexate beneficial to patients with acute lymphoblastic leukemia?Ching-Hon Pui, Mary V Relling, William E Evans
Pageof 30

Showing results (1-10 of 295) with videos related to

Sort By:
Pageof 30
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|November 3, 2012
Pharmacogenomics of adverse effects of anti-leukemic agents in childrenMary V Relling
Lancet (London, England)|September 15, 2004
Can the genotoxicity of chemotherapy be predicted?Ching-Hon Pui, Mary V Relling
Nature|May 28, 2004
Moving towards individualized medicine with pharmacogenomicsWilliam E Evans, Mary V Relling
Nature|October 16, 2015
Pharmacogenomics in the clinicMary V Relling, William E Evans
Hematology. American Society of Hematology. Education Program|December 10, 2013
Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacyMary V Relling, Laura B Ramsey
Pediatric Blood & Cancer|November 23, 2017
How to solve the problem of hypersensitivity to asparaginase?Ching-Hon Pui, Yiwei Liu, Mary V Relling
Blood|May 23, 2015
Inherited genetic variation in childhood acute lymphoblastic leukemiaTakaya Moriyama, Mary V Relling, Jun J Yang
Clinical Pharmacology and Therapeutics|September 15, 2019
Preemptively Precise: Returning and Updating Pharmacogenetic Test Results to Realize the Benefits of Preemptive TestingCyrine E Haidar, Mary V Relling, James M Hoffman
Nature Clinical Practice. Oncology|December 13, 2007
Are children with lesser-risk B-lineage acute lymphoblastic leukemia curable with antimetabolite therapy?Ching-Hon Pui, William E Evans, Mary V Relling
Leukemia & Lymphoma|December 16, 2006
Is mega dose of methotrexate beneficial to patients with acute lymphoblastic leukemia?Ching-Hon Pui, Mary V Relling, William E Evans
Pageof 30